Document Type

Article

Publication Date

3-1-2021

Publication Title

Experimental neurology

Keywords

JMG

JAX Source

Exp Neurol 2021 Mar; 337:113487

Volume

337

First Page

113587

Last Page

113587

ISSN

1090-2430

PMID

33382987

DOI

https://doi.org/10.1016/j.expneurol.2020.113587

Abstract

Spinal muscular atrophy (SMA) is a pediatric neuromuscular disease caused by genetic deficiency of the survival motor neuron (SMN) protein. Pathological hallmarks of SMA are spinal motor neuron loss and skeletal muscle atrophy. The molecular mechanisms that elicit and drive preferential motor neuron degeneration and death in SMA remain unclear. Transcriptomic studies consistently report p53 pathway activation in motor neurons and spinal cord tissue of SMA mice. Recent work has identified p53 as an inducer of spinal motor neuron loss in severe Δ7 SMA mice. Additionally, the cyclin-dependent kinase inhibitor P21 (Cdkn1a), an inducer of cell cycle arrest and mediator of skeletal muscle atrophy, is consistently increased in motor neurons, spinal cords, and other tissues of various SMA models. p21 is a p53 transcriptional target but can be independently induced by cellular stressors. To ascertain whether p53 and p21 signaling pathways mediate spinal motor neuron death in milder SMA mice, and how they affect the overall SMA phenotype, we introduced Trp53 and P21 null alleles onto the Smn

Comments

This article is licensed under a Creative Commons Attribution 4.0 International License.

Share

COinS